Barclays’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59.4K Sell
16,578
-136,471
-89% -$542K ﹤0.01% 4250
2025
Q4
$537K Buy
153,049
+3,656
+2% +$12.5K ﹤0.01% 3803
2025
Q3
$487K Sell
149,393
-25,045
-14% -$78.9K ﹤0.01% 3828
2025
Q2
$427K Buy
174,438
+7,556
+5% +$38.3K ﹤0.01% 3845
2025
Q1
$1.11M Sell
166,882
-67,070
-29% -$663K ﹤0.01% 3042
2024
Q4
$2.94M Buy
233,952
+78,978
+51% +$1.19M ﹤0.01% 2602
2024
Q3
$2.86M Buy
154,974
+24,177
+18% +$495K ﹤0.01% 2556
2024
Q2
$2.82M Buy
130,797
+25,292
+24% +$581K ﹤0.01% 1895
2024
Q1
$2.84M Sell
105,505
-72,030
-41% -$2.05M ﹤0.01% 2278
2023
Q4
$5.32M Buy
177,535
+23,126
+15% +$510K ﹤0.01% 2038
2023
Q3
$3.16M Buy
154,409
+11,192
+8% +$203K ﹤0.01% 1608
2023
Q2
$2.85M Sell
143,217
-17,925
-11% -$362K ﹤0.01% 1659
2023
Q1
$2.76M Sell
161,142
-19,083
-11% -$374K ﹤0.01% 1950
2022
Q4
$3.53M Buy
180,225
+30,392
+20% +$560K ﹤0.01% 1875
2022
Q3
$2.39M Buy
149,833
+32,480
+28% +$507K ﹤0.01% 1626
2022
Q2
$1.61M Sell
117,353
-388,191
-77% -$4.63M ﹤0.01% 2001
2022
Q1
$8.02M Buy
505,544
+66,360
+15% +$1.15M 0.01% 995
2021
Q4
$9.59M Buy
439,184
+238,788
+119% +$6.51M 0.01% 1290
2021
Q3
$5.99M Buy
200,396
+155,216
+344% +$5.65M ﹤0.01% 1506
2021
Q2
$2M Buy
45,180
+4,533
+11% +$197K ﹤0.01% 2192
2021
Q1
$1.8M Sell
40,647
-24,840
-38% -$1.36M ﹤0.01% 2369
2020
Q4
$3.59M Sell
65,487
-32,722
-33% -$1.19M ﹤0.01% 1767
2020
Q3
$2.25M Buy
98,209
+35,122
+56% +$865K ﹤0.01% 2001
2020
Q2
$1.32M Sell
63,087
-184,668
-75% -$3.33M ﹤0.01% 2499
2020
Q1
$3.46M Buy
247,755
+214,682
+649% +$4.25M 0.01% 1784
2019
Q4
$754K Buy
33,073
+15,195
+85% +$254K ﹤0.01% 3924
2019
Q3
$208K Sell
17,878
-4,060
-19% -$50.4K ﹤0.01% 4938
2019
Q2
$329K Buy
21,938
+526
+2% +$9.18K ﹤0.01% 4693
2019
Q1
$376K Buy
+21,412
New +$338K ﹤0.01% 4339
2018
Q4
Sell
-16,931
Closed -$417K 7276
2018
Q3
$417K Buy
16,931
+8,775
+108% +$190K ﹤0.01% 4425
2018
Q2
$160K Sell
8,156
-27,944
-77% -$529K ﹤0.01% 4909
2018
Q1
$677K Buy
36,100
+29,474
+445% +$481K ﹤0.01% 3643
2017
Q4
$69K Buy
6,626
+6,625
+662,500% +$65.7K ﹤0.01% 5527
2017
Q3
$0 Sell
1
-7,036
-100% -$32.2K ﹤0.01% 7018
2017
Q2
$53K Buy
7,037
+3,441
+96% +$25.7K ﹤0.01% 5331
2017
Q1
$29K Sell
3,596
-1,927
-35% -$13K ﹤0.01% 5624
2016
Q4
$134K Buy
5,523
+5,495
+19,625% +$157K ﹤0.01% 4540
2016
Q3
$1K Sell
28
-56
-67% -$1.76K ﹤0.01% 6424
2016
Q2
$2K Buy
84
+50
+147% +$1.76K ﹤0.01% 5974
2016
Q1
$1K Sell
34
-88
-72% -$2.64K ﹤0.01% 5997
2015
Q4
$5K Buy
+122
New +$5.32K ﹤0.01% 5575

Other funds holding RCKT